methoxyhydroxyphenylglycol has been researched along with Respiratory Distress Syndrome, Newborn in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Helminen, T; Kallio, J; Karlsson, R; Kero, P; Scheinin, M; Toppari, J | 1 |
| Kallio, J; Karlsson, R; Kero, P; Scheinin, M; Toppari, J | 1 |
1 trial(s) available for methoxyhydroxyphenylglycol and Respiratory Distress Syndrome, Newborn
| Article | Year |
|---|---|
Antenatal dexamethasone treatment decreases plasma catecholamine levels in preterm infants.
Topics: Antihypertensive Agents; Birth Weight; Cyclic AMP; Delivery, Obstetric; Dexamethasone; Epinephrine; Female; Gestational Age; Humans; Hypertension; Infant, Newborn; Infant, Premature; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Pregnancy; Pregnancy Complications, Cardiovascular; Prenatal Care; Regression Analysis; Respiratory Distress Syndrome, Newborn; Tocolytic Agents | 1998 |
1 other study(ies) available for methoxyhydroxyphenylglycol and Respiratory Distress Syndrome, Newborn
| Article | Year |
|---|---|
Antenatal and early postnatal dexamethasone treatment decreases cortisol secretion in preterm infants.
Topics: Catecholamines; Cesarean Section; Cyclic AMP; Dexamethasone; Female; Gestational Age; Glucocorticoids; Humans; Hydrocortisone; Infant, Newborn; Infant, Premature; Methoxyhydroxyphenylglycol; Pregnancy; Respiratory Distress Syndrome, Newborn | 2000 |